Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

J Clin Psychopharmacol. 2008 Feb;28(1):110-3. doi: 10.1097/jcp.0b013e318160862c.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Asian People
  • Capsules
  • Curcuma*
  • Curcumin / administration & dosage
  • Curcumin / adverse effects
  • Curcumin / therapeutic use*
  • Double-Blind Method
  • Female
  • Hong Kong
  • Humans
  • Male
  • Phytotherapy*
  • Pilot Projects

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Capsules
  • Curcumin